Prognostic significance of lymphovascular invasion in radical prostatectomy specimens

BJU International

Volumn 110, Issue 10, 2012, Pages 1507-1514

  Ng, Jonathan ^a   Mahmud, Aamer ^a   Bass, Brenda ^a   Brundage, Michael ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

lymphovascular invasion; multivariate analysis; prognosis; prostatectomy; prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; GLEASON SCORE; HUMAN; LYMPH VESSEL METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84868208390     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11115.x     Document Type: Article

References (32)

1. Sutcliffe P, Hummel S, Simpson E, et al,. Use of Classical and novel biomarkers as prognostic risk factors for localised prostae cancer: a systematic review. Health Technol Assess 2009; 13: 1-242
2. D'Amico AV, Whittington R, Malkowicz SB, et al,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74 (Pubitemid 28445094)
3. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW,. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008; 107: 309-30 (Pubitemid 351172108)
4. Magi-Galluzzi C, Evans AJ, Delahunt B, et al,. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Modern Pathol 2011; 24: 26-38
5. Harnden P, Shelley MD, Clements H, et al,. The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. Cancer 2007; 109: 13-24 (Pubitemid 46120190)
6. Cookson MS, Aus G, Burnett AL, et al,. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007; 177: 540-5 (Pubitemid 46054056)
7. McShane LM, Altman DG, Sauerbrei W, et al,. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 2005; 23: 9067-72
8. Henson DE, Hutter RV, Farrow G,. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the Cancer Committee, College of American Pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer. Arch PathLab Med 1994; 118: 779-83 (Pubitemid 24249111)
9. Babaian RJ, Troncoso P, Bhadkamkar VA, Johnston DA,. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 2001; 91: 1414-22 (Pubitemid 32319250)
10. Baydar DE, Baseskioglu B, Ozen H, Geyik PO,. Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy. TSWJ 2008; 8: 303-12 (Pubitemid 351549498)
11. Cheng L, Jones TD, Lin H, et al,. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 2005; 174: 2181-5 (Pubitemid 41611770)
12. Engers R, Ziegler S, Mueller M, Walter A, Willers R, Gabbert HE,. Prognostic relevance of increased Rac GTPase expression in prostate carcinomas. Endocr Relat Cancer 2007; 14: 245-56 (Pubitemid 47242626)
13. Epstein JI, Partin AW, Potter SR, Walsh PC,. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2004; 56: 283-8 (Pubitemid 30495584)
14. Ferrari MK, McNeal JE, Malhotra SM, Brooks JD,. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Urology 2004; 64: 749-53 (Pubitemid 39446056)
15. Herman CM, Wilcox GE, Kattan MW, Scardino PT, Wheeler TM,. Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am J Surg Pathol 2000; 24: 859-63 (Pubitemid 30366274)
16. Huang SP, Huang CY, Wang JS, et al,. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy. Clin Cancer Res 2007; 13: 6632-8
17. Ito K, Nakashima J, Mukai M, et al,. Prognostic implication of microvascular invasion in biochemical failure in patients treated with radical prostatectomy. Urol Int 2003; 70: 297-302 (Pubitemid 36566261)
18. Lee KL, Marotte JB, Ferrari MK, McNeal JE, Brooks JD, Presti JC Jr,. Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology 2005; 65: 311-5 (Pubitemid 40248019)
19. Loeb S, Roehl KA, Yu X, et al,. Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression. Urology 2006; 68: 99-103 (Pubitemid 44037752)
20. May M, Kaufmann O, Hammermann F, Loy V, Siegsmund M,. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. BJU Int 2007; 99: 539-44 (Pubitemid 46238825)
21. Mian BM, Troncoso P, Okihara K, et al,. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 2002; 167: 1675-80 (Pubitemid 34240700)
22. Quinn DI, Henshall SM, Haynes AM, et al,. Prognostic significance of pathologic features in localized prostate cancer with radical prostectomy: implications for staging systems and predictive models. J Clin Oncol 2001; 19: 3692-705 (Pubitemid 32786282)
23. Shariat SF, Khoddami SM, Saboorian H, et al,. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 2004; 171: 1122-7 (Pubitemid 38327540)
24. Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM,. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 2000; 163: 1155-60 (Pubitemid 30169382)
25. Svatek RS, Karam JA, Roehrborn CG, Karakiewicz PI, Slawin KM, Shariat SF,. Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clin Cancer Res 2008; 14: 3362-6
26. Whittemore DE, Hick EJ, Carter MR, Moul JW, Miranda-Sousa AJ, Sexton WJ,. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens. J Urol 2008; 179: 516-22; discussion 522
27. Yoshimoto M, Joshua AM, Cunha IW, et al,. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Modern Pathol 2008; 21: 1451-60
28. Montori VM, Smieja M, Guyatt GH,. Publication bias: a brief review for clinicians. Mayo Clinic Proc 2000; 75: 1284-8
29. Oxman AD, Guyatt GH,. Guidelines for reading literature reviews. CMAJ. Can Med Assoc J 1988; 138: 697-703
30. Mizuno R, Nakashima J, Mukai M, et al,. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer. BJU Int 2009; 104: 1215-8
31. Yamamoto S, Kawakami S, Yonese J, et al,. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer. Int J Urol 2008; 15: 895-9
32. Jeon HG, Bae J, Yi JS, Hwang IS, Lee SE, Lee E,. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy. Int J Urol 2009; 16: 682-6